...
首页> 外文期刊>Japan Chemical Daily >Mitsubishi Chemical Holdings Eyes Biotech Conversion, Overseas Capital Investment With Full-Scale Petrochemical Restructuring
【24h】

Mitsubishi Chemical Holdings Eyes Biotech Conversion, Overseas Capital Investment With Full-Scale Petrochemical Restructuring

机译:三菱化学生物技术控股眼睛转换,海外资本投资全面石化重组

获取原文
获取原文并翻译 | 示例
           

摘要

Mitsubishi Chemical Holdings Corp. (MCHC; TYO:4188) is planning an April 2023 launch of a wholly owned subsidiary for its petrochemical and carbon operations, with the chemicals conglomerate embarking here on a path of separation and restructuring. The Chemical Daily recently had the opportunity to speak with Representative Managing Corporate Executive O?cer Yoshihiro Ikegawa, who is set to assume an executive VP role for the company’s petrochemical and carbon operations on April 1.
机译:三菱化学控股公司(MCHC;莫:4188)计划2023年4月发射石化和全资子公司碳操作,化学物质集团开始在这里的道路分离和重组。最近有机会说话代表公司执行总经理啊?喜田岛Ikegawa,谁将承担一个执行副总裁为公司的石化作用4月1日和碳操作。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号